No abstract available
Keywords:
Actemra; COVID-19; Olumiant; Veklury; adverse effects; anakinra; baricitinib; corticosteroids; dexamethasone; dosage; drug interactions; efficacy; lactation; pregnancy; remdesivir; safety; tocilizumab.
MeSH terms
-
Antibodies, Monoclonal
-
COVID-19*
-
Humans
-
Interleukin 1 Receptor Antagonist Protein / adverse effects
-
SARS-CoV-2
Substances
-
Interleukin 1 Receptor Antagonist Protein
-
Antibodies, Monoclonal